Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
暂无分享,去创建一个
K. Reich | H. Villesen | A. Kroker | C. Gessner | W. Emminger | W. Pohl | E. Wüstenberg | Jan-Alexander Schwab